A. O. U. Pisana - Ospedale S. Chiara
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fontana, Andrea
FOENIX-MBC2 TAS-120-201, NCT04024436: A Study of TAS-120 in Patients With Metastatic Breast Cancer

Active, not recruiting
2
168
Europe, Canada, US
Futibatinib, TAS-120, Futibatinib plus Fulvestrant
Taiho Oncology, Inc.
Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification
05/23
07/24
BIO-META, NCT02284581: Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments

Recruiting
N/A
10000
Europe
Consorzio Oncotech
Metastatic Breast Cancer
06/23
12/25
NCT06137833: Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Adjuvant Chemotherapy

Not yet recruiting
N/A
92
Europe
APPOPRTALĀ®, Placebo
Pharmanutra S.p.a., Latis S.r.l.
Fatigue, Breast Cancer
09/24
12/24
NCT05754502: Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Recruiting
N/A
300
Europe
Trastuzumab emtansine
Consorzio Oncotech, Roche Pharma AG
Breast Cancer
09/24
05/25

Download Options